ClinicalTrials.gg
Sign In

Hepatitis D, Chronic clinical trials

The registry lists 43 studies for Hepatitis D, Chronic across more than 10 countries. 9 are recruiting or about to start. 35 of them are mainly about Hepatitis D, Chronic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Hepatitis D, Chronic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
19
Active, not recruiting
6
Recruiting
6
Status unknown
5
Not yet recruiting
2
Terminated
2

Phase

Phase 2
20
Phase 3
9
Phase 1
4
Phase 4
1

Where

Germany
12
Romania
11
Italy
10
United States
9
France
9
United Kingdom
8

Who runs them

Gilead Sciences (5) · EIT Pharma, Inc. (4) · Hoffmann-La Roche (4) · Vir Biotechnology, Inc. (4) · Mirum Pharmaceuticals, Inc. (2) · Shanghai HEP Pharmaceutical Co., Ltd. (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Eiger BioPharmaceuticals (1)

What is being tested here

Drugs under test in Hepatitis D, Chronic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Bulevirtide123
Hepalatide112
Brelovitug111
Tobevibart024
Elebsiran024
Ritonavir013
Peginterferon alfa-2a013
Lonafarnib012
Peginterferon lambda-1a002
Ezetimibe002

Coming up

4phase 3 studies under way
4studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Who these studies take

Of the 6 Hepatitis D, Chronic studies recruiting now, 4 (67%) set no upper age limit and 2 (33%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
100 (0%)0 (0%)
186 (100%)6 (100%)
306 (100%)6 (100%)
406 (100%)6 (100%)
506 (100%)6 (100%)
656 (100%)6 (100%)
754 (67%)4 (67%)
854 (67%)4 (67%)

Across all 43 studies, recruiting or not: 51% stop at 75 or younger and 35% at 65; 2% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 43 of 43. search them.